Journal profile · Ophthalmology
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
ISSN 0275-004X · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1981
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.06; JCR Q3 (journal website); hybrid open access; review 3–6 weeks (community reports); community-reported acceptance: easy; 368 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Retinal Diseases and Treatments, Retinal and Macular Surgery and Ocular Diseases and Behçet’s Syndrome, together about 43.7% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.
Source: LetPub
Research area (LetPub): Ophthalmology
Editor-in-chief Alexander J. BruckerPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Retinal Diseases and TreatmentsMedicine18.1%
- Retinal and Macular SurgeryMedicine17%
- Ocular Diseases and Behçet’s SyndromeMedicine8.6%
- Intraocular Surgery and LensesMedicine8.5%
- Retinal and Optic ConditionsMedicine7.2%
- Glaucoma and retinal disordersMedicine6.4%
- Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology4.8%
- Retinal Imaging and AnalysisMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Ophthalmology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Ophthalmology | Zone 2 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · OPHTHALMOLOGY · rank 51/98
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.06LetPub ·
- Impact factor (publisher)
- 2.1Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 1.19LetPub ·
- h-index
- 105LetPub ·
- h-index
- 173OpenAlex ·
- i10-index
- 6,055OpenAlex ·
- 2-year mean citedness
- 1.55OpenAlex ·
- Self-citation rate
- 9.5%LetPub ·
- Share of gold OA articles
- 16.53%LetPub ·
Volume
- Articles per year
- 308LetPub ·
Articles by year OpenAlex count · 12,004 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 274 | 36 | 49 |
| 2025 | 368 | 68 | 454 |
| 2024 | 357 | 94 | 1,047 |
| 2023 | 368 | 73 | 2,216 |
| 2022 | 264 | 66 | 2,308 |
| 2021 | 350 | 73 | 3,170 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1981
- ISSN
- 0275-004X
- Print ISSN
- 1539-2864
- Latest issue on the website
- Volume 46, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
What CAS zone is RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES in?
In the 2025 upgraded edition of the CAS Journal Ranking, RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES is in Zone 3 of Medicine, and in Zone 3 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES?
The latest impact factor listed by LetPub is 2.06; CiteScore 3.8, h-index 173.
How long does peer review take at RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES?
Authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES in?
The journal's website gives JCR Q3; by category, OPHTHALMOLOGY Q3 (51/98). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES?
According to LetPub and DOAJ records, RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES is indexed in SCIE and Scopus.
Is RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES open access, and what is the APC?
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .